Skip to main content


Teams of the IPBS are leaders in the discovery, characterization and exploitation of novel pathways and pharmacological targets in the fields of cancer, infectious diseases and inflammatory disorders, through the use of molecular and cellular biology approaches, together with in vivo experiments, including BSL-3-based studies of infectious diseases.
We conduct state-of-the-art research in structural biology, proteomics, biophysics, cancerology, immunology and microbiology.